BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8603418)

  • 1. Subcellular redistribution of DNA topoisomerase I in anaplastic astrocytoma cells treated with topotecan.
    Danks MK; Garrett KE; Marion RC; Whipple DO
    Cancer Res; 1996 Apr; 56(7):1664-73. PubMed ID: 8603418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intermittent exposure of medulloblastoma cells to topotecan produces growth inhibition equivalent to continuous exposure.
    Danks MK; Pawlik CA; Whipple DO; Wolverton JS
    Clin Cancer Res; 1997 Oct; 3(10):1731-8. PubMed ID: 9815557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA synthesis inhibitors alter the subnuclear distribution of DNA topoisomerase I.
    Buckwalter CA; Lin AH; Tanizawa A; Pommier YG; Cheng YC; Kaufmann SH
    Cancer Res; 1996 Apr; 56(7):1674-81. PubMed ID: 8603419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamics of topoisomerase I inhibition: Western blot determination of topoisomerase I and cleavable complex in patients with upper gastrointestinal malignancies treated with topotecan.
    Liebes L; Potmesil M; Kim T; Pease D; Buckley M; Fry D; Cho J; Adler H; Dar K; Zeleniuch-Jacquotte A; Hochster H
    Clin Cancer Res; 1998 Mar; 4(3):545-57. PubMed ID: 9533521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caffeine prevents apoptosis and cell cycle effects induced by camptothecin or topotecan in HL-60 cells.
    Traganos F; Kapuscinski J; Gong J; Ardelt B; Darzynkiewicz RJ; Darzynkiewicz Z
    Cancer Res; 1993 Oct; 53(19):4613-8. PubMed ID: 8402636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liposomal encapsulation increases the activity of the topoisomerase I inhibitor topotecan.
    Subramanian D; Muller MT
    Oncol Res; 1995; 7(9):461-9. PubMed ID: 8835290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of P-glycoprotein expression on the accumulation and cytotoxicity of topotecan (SK&F 104864), a new camptothecin analogue.
    Hendricks CB; Rowinsky EK; Grochow LB; Donehower RC; Kaufmann SH
    Cancer Res; 1992 Apr; 52(8):2268-78. PubMed ID: 1348448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note.
    Kaufmann SH
    Cancer Res; 1989 Nov; 49(21):5870-8. PubMed ID: 2790800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic cell killing by ionizing radiation and topoisomerase I inhibitor topotecan (SK&F 104864).
    Mattern MR; Hofmann GA; McCabe FL; Johnson RK
    Cancer Res; 1991 Nov; 51(21):5813-6. PubMed ID: 1657371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human DNA topoisomerase I: quantitative analysis of the effects of camptothecin analogs and the benzophenanthridine alkaloids nitidine and 6-ethoxydihydronitidine on DNA topoisomerase I-induced DNA strand breakage.
    Holden JA; Wall ME; Wani MC; Manikumar G
    Arch Biochem Biophys; 1999 Oct; 370(1):66-76. PubMed ID: 10496978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of topoisomerase I/DNA complexes in patients administered topotecan.
    Subramanian D; Kraut E; Staubus A; Young DC; Muller MT
    Cancer Res; 1995 May; 55(10):2097-103. PubMed ID: 7743509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumour drugs impede DNA uncoiling by topoisomerase I.
    Koster DA; Palle K; Bot ES; Bjornsti MA; Dekker NH
    Nature; 2007 Jul; 448(7150):213-7. PubMed ID: 17589503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topotecan-induced alterations in the amount and stability of human DNA topoisomerase I in solid tumor cell lines.
    Devy J; Wargnier R; Pluot M; Nabiev I; Sukhanova A
    Anticancer Res; 2004; 24(3a):1745-51. PubMed ID: 15274350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topotecan-induced topoisomerase IIalpha expression increases the sensitivity of the CML cell line K562 to subsequent etoposide plus mitoxantrone treatment.
    Chen S; Gomez SP; McCarley D; Mainwaring MG
    Cancer Chemother Pharmacol; 2002 May; 49(5):347-55. PubMed ID: 11976828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective schedules of exposure of medulloblastoma and rhabdomyosarcoma xenografts to topotecan correlate with in vitro assays.
    Pawlik CA; Houghton PJ; Stewart CF; Cheshire PJ; Richmond LB; Danks MK
    Clin Cancer Res; 1998 Aug; 4(8):1995-2002. PubMed ID: 9717830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterisation of a human small-cell lung cancer cell line resistant to the DNA topoisomerase I-directed drug topotecan.
    Sorensen M; Sehested M; Jensen PB
    Br J Cancer; 1995 Aug; 72(2):399-404. PubMed ID: 7640225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subcellular localization of the camptothecin analogues, topotecan and gimatecan.
    Croce AC; Bottiroli G; Supino R; Favini E; Zuco V; Zunino F
    Biochem Pharmacol; 2004 Mar; 67(6):1035-45. PubMed ID: 15006540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression of Bcl-XL, Bcl-XS and p27Kip1 in topotecan-induced apoptosis in hepatoblastoma HepG2 cell line.
    Zhang J; Cheng C; He CL; Zhou YJ; Cao Y
    Cancer Invest; 2008 Jun; 26(5):456-63. PubMed ID: 18568767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of topotecan-mediated redistribution of DNA topoisomerase I by digital imaging microscopy.
    Wadkins RM; Danks MK; Horowitz L; Baker SD
    Exp Cell Res; 1998 Jun; 241(2):332-9. PubMed ID: 9637775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex.
    Hofland K; Petersen BO; Falck J; Helin K; Jensen PB; Sehested M
    Clin Cancer Res; 2000 Apr; 6(4):1488-97. PubMed ID: 10778981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.